Queen's University Belfast
Northern Ireland-Based Cancer Dx Firm GenoMe Diagnostics Raises £1.4M
The Queen's University Belfast spinout plans to develop a blood test called OvaMe for the early detection of ovarian cancer.
The test relies on a signature that Almac developed for stratifying breast cancer patients, but which, as the researchers showed, can be used in other cancers as well.
First Sequences of Ancient Irish Human Genomes Support Mass Migration History
The genetic evidence supports a link between migrations and important cultural shifts like the emergence of agriculture or metal tools occurring in parallel.
By Justin Petrone
Almac Diagnostics has moved closer to launching its microarray-based test for stage II colorectal cancer recurrence and plans to debut it in the US sometime next year.
Sep 7, 2011